NOS3 and peripheral arterial disease: The data presented in this review supports their potential use in PAD and DFU and address their key mechanisms: reduction of oxidative stress, enhancement of blood flow through neovascularization as well as angiogenesis and promotion of vasodilation via NO production from eNOS.